Cargando...
Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy
Patients with diabetes type 2 have an increased risk for cardiovascular disease and commonly use combination therapy consisting of the anti-diabetic drug metformin and a cholesterol-lowering statin. However, both drugs act on glucose and lipid metabolism which could lead to adverse effects when used...
Gardado en:
| Publicado en: | Cardiovasc Diabetol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioMed Central
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6026339/ https://ncbi.nlm.nih.gov/pubmed/29960584 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-018-0738-4 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|